← Leaderboards
Won Jun Kim
Weill Medical Coll Of Cornell Univ
$108,512
Attributed
$108,512
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2024–25$100K$75K$50K$25K$0
'24
'25
Funding mix
By agency
NIH$108,512 · 1
By mechanism
F30$108,512 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Steven Monroe Lipkin$27,661,021
- Nasser Khaled Altorki$2,970,612
- Vivek Mittal$10,850,597
- Olivier Elemento$10,592,678
- Alain C Borczuk$997,395
Others in their field
Other Rising Stars on “Acute Myelocytic Leukemia”
- Michael E. Roth · Public Health Institute$8,303,012
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Jeevisha Bajaj · University Of Rochester$2,438,184
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Angela Goffredo Fleischman · University Of California-Irvine$2,306,090
Research focus
Acute Myelocytic LeukemiaAffinityAdaptive ImmunityAlternative SplicingAnimalsAntigensBar CodesAllelesBone MarrowCandidate ValidationCareer ChoiceCd8-Positive T-LymphocytesCell LineCellsCellular TransductionClinical ImplementationBindingClustered Regularly Interspaced Short Palindromic RepeatsCoculture TechniquesData SetDoctoral StudentDoctor Of PhilosophyDysmyelopoietic SyndromesEngineered T Cells
Grant awards (2)
Identifying mis-splicing-derived antigens in spliceosomal mutant myelodysplasia and targeting via T-cell receptor therapeutics$54,538
F30 · FY2025 · HL · contact PI
Identifying mis-splicing-derived antigens in spliceosomal mutant myelodysplasia and targeting via T-cell receptor therapeutics$53,974
F30 · FY2024 · HL · contact PI